Complete Filing Data
Cullinan Therapeutics, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $408.73 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cullinan Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$219.9M | -$167.4M | -$153.2M | $111.2M | -$65.6M | -$51.8M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $1.2M | -$4.0K | $2.5M | -$1.8M | -$836.0K | $2.0K |
| Research And Development Expense | $187.4M | $142.9M | $148.2M | $91.9M | $57.8M | $43.2M |
| Operating Income Loss | -$241.6M | -$196.9M | -$191.1M | $144.6M | -$68.0M | -$60.3M |
| Operating Expenses | $241.6M | $196.9M | $190.6M | $132.1M | $86.9M | $60.3M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | -$192.0K | -$1.9M | -$2.0M | -$1.9M | -$7.7M |
| General And Administrative Expense | $54.2M | $54.0M | $42.5M | $40.2M | $29.1M | $17.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$218.7M | -$167.6M | -$152.6M | $107.4M | -$68.3M | -$59.5M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | -$192.0K | -$1.9M | -$2.0M | -$1.9M | -$7.7M |
| Comprehensive Income Net Of Tax | -$218.7M | -$167.4M | -$150.7M | $109.5M | -$66.4M | -$51.8M |
| Other Nonoperating Income Expense | -$443.0K | -$199.0K | $239.0K | $57.0K | -$8.0K | -$11.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $2.5M | -$1.8M | -$836.0K | $2.0K | ||
| Income Taxes Paid Net | -$3.0M | -$2.3M | -$4.4M | $37.8M | $0.00 | |
| Income Tax Expense Benefit | $0.00 | $117.0K | -$14.1M | $42.1M | $0.00 | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$219.9M | -$167.5M | -$169.2M | $151.3M | -$67.5M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $18.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$50.6M | -$70.1M | -$48.5M | -$40.6M | -$42.0M | -$37.1M | -$39.2M | -$32.2M | -$58.0M | -$24.8M | $174.9M | -$12.1M | -$17.4M | -$15.6M | -$70.0K | -$9.9M | -$8.6M | -$5.0M |
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $366.0K | $102.0K | $638.0K | $1.4M | -$145.0K | -$202.0K | $574.0K | -$383.0K | $1.4M | -$296.0K | -$499.0K | -$2.3M | $57.0K | -$55.0K | -$58.0K | -$144.0K | $177.0K | $30.0K |
| Research And Development Expense | $42.0M | $61.0M | $41.5M | $35.5M | $36.3M | $30.6M | $33.8M | $27.4M | $52.1M | $19.7M | $26.4M | $24.5M | $12.7M | $11.8M | $12.4M | $9.9M | $12.5M | $4.2M |
| Operating Income Loss | -$55.6M | -$75.8M | -$55.0M | -$48.9M | -$50.0M | -$43.0M | -$45.2M | -$37.6M | -$62.8M | -$29.8M | $239.7M | -$32.7M | -$18.4M | -$16.6M | $1.4M | -$11.5M | -$14.1M | -$5.5M |
| Operating Expenses | $55.6M | $75.8M | $55.0M | $48.9M | $50.0M | $43.0M | $44.8M | $37.6M | $62.8M | $29.8M | $37.1M | $32.7M | $18.4M | $16.6M | $17.6M | $11.5M | $14.1M | $5.5M |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$192.0K | $0.00 | $0.00 | -$179.0K | -$86.0K | -$833.0K | -$794.0K | -$909.0K | -$803.0K | $1.5M | -$1.5M | -$5.3M | -$190.0K |
| General And Administrative Expense | $13.6M | $14.8M | $13.5M | $13.3M | $13.8M | $12.3M | $11.0M | $10.2M | $10.7M | $10.1M | $10.7M | $8.1M | $5.7M | $4.8M | $5.2M | $1.6M | $1.6M | $1.4M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$50.2M | -$70.0M | -$47.9M | -$39.1M | -$42.2M | -$37.5M | -$38.6M | -$32.6M | -$56.8M | -$25.2M | $173.6M | -$15.2M | -$18.2M | -$16.5M | $1.4M | -$11.5M | -$13.7M | -$5.1M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$192.0K | $0.00 | $0.00 | -$179.0K | -$86.0K | -$833.0K | -$794.0K | -$909.0K | -$803.0K | $1.5M | -$1.5M | -$5.3M | -$190.0K |
| Comprehensive Income Net Of Tax | -$50.2M | -$70.0M | -$47.9M | -$39.1M | -$42.2M | -$37.4M | -$38.6M | -$32.6M | -$56.6M | -$25.1M | $174.4M | -$14.4M | -$17.3M | -$15.7M | -$128.0K | -$10.0M | -$8.4M | -$4.9M |
| Other Nonoperating Income Expense | -$108.0K | -$181.0K | -$85.0K | -$89.0K | -$72.0K | -$44.0K | $180.0K | $69.0K | $107.0K | $0.00 | -$241.0K | $0.00 | -$2.0K | -$8.0K | -$2.0K | $1.0K | ||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$296.0K | -$499.0K | -$2.3M | $57.0K | -$55.0K | -$58.0K | -$144.0K | $177.0K | $30.0K | |||||||||
| Income Taxes Paid Net | $0.00 | -$3.9M | $75.0K | $0.00 | ||||||||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$2.5M | $66.1M | -$19.6M | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$39.2M | -$32.2M | -$58.1M | -$27.4M | $240.1M | -$32.5M | -$18.3M | -$16.4M | $1.4M | |||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $18.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $408.7M | $590.3M | $453.7M | $535.0M | $425.0M | $199.0M | $97.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $88.3M | $83.0M | $98.4M | $156.2M | $59.8M | $168.2M | $63.3M |
| Retained Earnings Accumulated Deficit | -$588.1M | -$368.2M | -$200.9M | -$47.7M | -$158.9M | -$93.3M | -$41.5M |
| Minority Interest | $0.00 | $0.00 | $192.0K | $0.00 | $403.0K | $1.3M | $864.0K |
| Common Stock Value | $6.0K | $6.0K | $4.0K | $5.0K | $4.0K | $3.0K | $2.0K |
| Additional Paid In Capital Common Stock | $995.8M | $958.7M | $654.7M | $585.3M | $584.7M | $292.3M | $138.5M |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.0M | -$133.0K | -$129.0K | -$2.6M | -$838.0K | -$2.0K | -$4.0K |
| Short Term Investments | $289.6M | $316.0M | $368.6M | $311.1M | $230.7M | $42.0M | |
| Property Plant And Equipment Net | $421.0K | $683.0K | $989.0K | $1.2M | $77.0K | $130.0K | |
| Other Assets Noncurrent | $297.0K | $366.0K | $459.0K | $459.0K | $147.0K | $2.3M | |
| Liabilities Current | $37.7M | $30.6M | $28.1M | $22.5M | $11.7M | $14.3M | |
| Liabilities And Stockholders Equity | $448.4M | $621.8M | $484.2M | $561.1M | $437.2M | $214.7M | |
| Liabilities | $39.6M | $31.5M | $30.3M | $26.1M | $11.8M | $14.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.3M | -$15.4M | -$57.7M | $96.4M | -$108.4M | $104.9M | |
| Cash And Cash Equivalents At Carrying Value | $88.3M | $83.0M | $98.4M | $156.2M | $59.8M | $168.2M | |
| Assets Current | $386.8M | $414.7M | $480.2M | $474.5M | $296.6M | $212.3M | |
| Assets | $448.4M | $621.8M | $484.2M | $561.1M | $437.2M | $214.7M | |
| Amortization Accretion On Marketable Securities | -$6.3M | -$15.5M | -$10.2M | $1.3M | $3.1M | $233.0K | |
| Accrued Liabilities Current | $36.1M | $27.7M | $24.2M | $14.1M | $8.6M | $4.6M | |
| Accounts Payable Current | $841.0K | $1.7M | $2.5M | $2.7M | $3.2M | $9.7M | |
| Long Term Investments | $58.3M | $204.4M | $0.00 | $80.9M | $140.4M | $0.00 | |
| Operating Lease Right Of Use Asset | $2.6M | $1.7M | $2.5M | $4.1M | $0.00 | ||
| Operating Lease Liability Noncurrent | $1.9M | $849.0K | $2.2M | $3.6M | $871.0K | ||
| Operating Lease Liability Current | $780.0K | $1.3M | $1.4M | $1.4M | $505.0K | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Gain Loss On Disposition Of Non Financial Assets | $0.00 | $276.8M | $0.00 | ||||
| Non Cash Contributions From Noncontrolling Interests | $0.00 | $131.0K | $374.0K | $67.0K | |||
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $2.1M | $1.5M | $990.0K | ||||
| Deferred Rent Credit Noncurrent | $0.00 | $65.0K | $74.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $451.4M | $492.1M | $551.8M | $627.9M | $656.2M | $425.7M | $468.8M | $499.6M | $485.6M | $586.1M | $604.5M | $418.7M | $443.4M | $455.5M | $466.9M | $87.6M | $97.7M | $106.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $103.3M | $72.8M | $76.7M | $102.1M | $115.0M | $74.2M | $64.8M | $141.8M | $122.1M | $242.7M | $353.6M | $76.1M | $88.1M | $123.7M | $293.5M | $41.3M | $51.1M | $45.4M |
| Retained Earnings Accumulated Deficit | -$537.4M | -$486.8M | -$416.7M | -$320.6M | -$280.0M | -$238.0M | -$177.1M | -$137.9M | -$105.7M | -$20.9M | $3.9M | -$171.0M | -$126.4M | -$109.0M | -$93.4M | -$65.0M | -$55.1M | |
| Minority Interest | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $80.0K | $768.0K | $2.1M | $3.0M | $2.8M | $1.9M | $1.3M | |
| Common Stock Value | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $4.0K | $4.0K | $4.0K | $4.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | |
| Additional Paid In Capital Common Stock | $987.8M | $978.3M | $968.1M | $947.5M | $936.7M | $664.0M | $646.9M | $639.1M | $592.5M | $611.0M | $604.3M | $592.8M | $569.8M | $564.7M | $560.4M | $152.6M | $152.6M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $973.0K | $607.0K | $505.0K | $970.0K | -$476.0K | -$331.0K | -$1.1M | -$1.6M | -$1.2M | -$3.9M | -$3.6M | -$3.1M | -$58.0K | -$115.0K | -$60.0K | $59.0K | $203.0K | |
| Short Term Investments | $229.3M | $192.7M | $227.2M | $476.0M | $547.5M | $358.8M | $401.6M | $350.0M | $268.6M | $333.3M | $257.4M | $238.7M | $232.9M | $213.0M | $147.3M | |||
| Property Plant And Equipment Net | $489.0K | $569.0K | $607.0K | $760.0K | $836.0K | $913.0K | $1.1M | $1.2M | $1.2M | $792.0K | $52.0K | $64.0K | $89.0K | $102.0K | $115.0K | |||
| Other Assets Noncurrent | $361.0K | $367.0K | $366.0K | $460.0K | $460.0K | $460.0K | $459.0K | $459.0K | $459.0K | $460.0K | $100.0K | $147.0K | $147.0K | $147.0K | $147.0K | |||
| Liabilities Current | $32.8M | $28.1M | $27.3M | $24.2M | $23.5M | $21.9M | $23.4M | $19.7M | $26.2M | $27.1M | $62.0M | $17.3M | $7.9M | $5.7M | $9.9M | |||
| Liabilities And Stockholders Equity | $484.1M | $520.3M | $579.7M | $653.3M | $681.2M | $449.4M | $494.7M | $522.0M | $515.0M | $617.2M | $667.2M | $437.5M | $453.4M | $464.4M | $479.7M | |||
| Liabilities | $32.8M | $28.2M | $27.8M | $25.4M | $25.0M | $23.8M | $25.9M | $22.4M | $29.3M | $31.1M | $62.6M | $18.0M | $7.9M | $5.8M | $10.0M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$6.4M | -$24.2M | -$34.0M | $16.3M | $125.3M | -$17.9M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $103.3M | $72.8M | $76.7M | $102.1M | $115.0M | $74.2M | $64.8M | $141.8M | $122.1M | $242.7M | $353.6M | $76.1M | $88.1M | $123.7M | $293.5M | |||
| Assets Current | $342.2M | $275.9M | $317.8M | $592.0M | $677.8M | $445.7M | $476.7M | $498.2M | $399.0M | $582.1M | $622.8M | $322.3M | $328.8M | $344.5M | $447.3M | |||
| Assets | $484.1M | $520.3M | $579.7M | $653.3M | $681.2M | $449.4M | $494.7M | $522.0M | $515.0M | $617.2M | $667.2M | $437.5M | $453.4M | $464.4M | $479.7M | |||
| Amortization Accretion On Marketable Securities | -$2.3M | -$3.3M | -$1.4M | $946.0K | $229.0K | $25.0K | ||||||||||||
| Accrued Liabilities Current | $29.8M | $24.2M | $22.6M | $20.8M | $20.7M | $16.9M | $20.9M | $15.5M | $18.4M | $13.5M | $11.9M | $10.4M | $5.8M | $4.2M | $6.0M | |||
| Accounts Payable Current | $1.7M | $2.5M | $3.4M | $2.1M | $1.6M | $3.7M | $951.0K | $2.5M | $2.0M | $1.5M | $3.1M | $6.3M | $2.0M | $1.5M | $3.9M | |||
| Long Term Investments | $140.0M | $242.3M | $259.4M | $58.0M | $13.5M | $18.6M | $110.4M | $29.4M | $43.2M | $94.2M | $124.3M | $119.6M | $32.1M | |||||
| Operating Lease Right Of Use Asset | $1.0M | $1.2M | $1.6M | $2.0M | $2.1M | $2.3M | $2.9M | $3.5M | $3.8M | $4.5M | $1.1M | $1.2M | ||||||
| Operating Lease Liability Noncurrent | $0.00 | $125.0K | $493.0K | $1.2M | $1.5M | $1.8M | $2.4M | $2.7M | $3.2M | $4.0M | $596.0K | $736.0K | ||||||
| Operating Lease Liability Current | $1.2M | $1.4M | $1.3M | $1.3M | $1.2M | $1.3M | $1.5M | $1.7M | $1.6M | $696.0K | $533.0K | $519.0K | ||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Gain Loss On Disposition Of Non Financial Assets | $0.00 | $0.00 | $0.00 | $276.8M | $0.00 | $0.00 | ||||||||||||
| Non Cash Contributions From Noncontrolling Interests | $0.00 | $4.0K | $0.00 | |||||||||||||||
| Noncontrolling Interest Increase From Subsidiary Equity Issuance | $179.0K | $139.0K | $1.2M | |||||||||||||||
| Deferred Rent Credit Noncurrent | $0.00 | $0.00 | $0.00 | $67.0K | $70.0K | $73.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $36.0M | $37.8M | $30.4M | $28.0M | $24.4M | $14.9M |
| Proceeds From Sale And Maturity Of Marketable Securities | $416.6M | $584.8M | $409.4M | $352.9M | $192.0M | $62.9M |
| Net Cash Provided By Used In Operating Activities | -$175.8M | -$145.3M | -$134.3M | -$126.7M | -$43.4M | -$29.8M |
| Net Cash Provided By Used In Investing Activities | $180.0M | -$136.3M | $35.8M | $249.0M | -$333.8M | -$5.4M |
| Net Cash Provided By Used In Financing Activities | $1.1M | $266.2M | $40.8M | -$25.9M | $268.8M | $140.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$6.9M | $2.5M | $5.9M | $1.1M | $3.3M | $462.0K |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $8.0M | $2.9M | $10.1M | $8.5M | $4.6M | $1.8M |
| Increase Decrease In Accounts Payable | -$839.0K | -$812.0K | -$167.0K | -$509.0K | -$4.8M | $5.6M |
| Depreciation Depletion And Amortization | $311.0K | $306.0K | $310.0K | $93.0K | $53.0K | $62.0K |
| Share Based Compensation | $36.0M | $37.8M | $30.4M | $28.0M | $24.4M | $14.9M |
| Payments To Acquire Available For Sale Securities Debt | $236.5M | $721.1M | $373.4M | $377.9M | $525.8M | $69.8M |
| Payments To Acquire Property Plant And Equipment | $49.0K | $0.00 | $208.0K | $1.1M | $0.00 | $10.0K |
| Proceeds From Issuance Of Common Stock | $0.00 | $262.7M | $38.4M | $0.00 | $3.3M | $145.5M |
| Proceeds From Net Issuance Of Common Stock Under Equity Based Compensation Plans | $1.1M | $8.0M | $538.0K | $6.0M | ||
| Payments To Minority Shareholders | $0.00 | $4.4M | $0.00 | $33.3M | $0.00 | |
| Increase Decrease In Accrued Income Taxes Payable | $0.00 | -$4.3M | $4.3M | $0.00 | ||
| Proceeds From Issuance Initial Public Offering | $0.00 | $267.3M | ||||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $1.8M | $2.4M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $9.5M | $9.9M | $9.4M | $9.4M | $10.5M | $8.2M | $7.7M | $7.9M | $7.3M | $5.3M | $8.6M | $6.6M | $4.6M | $4.2M | $3.5M | |
| Proceeds From Sale And Maturity Of Marketable Securities | $162.6M | $144.3M | $104.5M | $91.7M | $12.0M | $4.2M | ||||||||||
| Net Cash Provided By Used In Operating Activities | -$43.2M | -$38.2M | -$51.0M | -$21.9M | -$1.5M | -$5.0M | ||||||||||
| Net Cash Provided By Used In Investing Activities | $36.8M | $13.0M | $15.2M | $34.7M | -$137.7M | -$26.9M | ||||||||||
| Net Cash Provided By Used In Financing Activities | $0.00 | $1.1M | $1.8M | $3.5M | $264.6M | $14.0M | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.7M | -$411.0K | $755.0K | $1.1M | $4.4M | -$693.0K | ||||||||||
| Increase Decrease In Accrued Expenses And Other Current Liabilities | -$5.3M | -$7.5M | $2.6M | $1.0M | $1.8M | -$756.0K | ||||||||||
| Increase Decrease In Accounts Payable | $1.7M | $1.2M | -$630.0K | $3.1M | -$4.1M | $170.0K | ||||||||||
| Depreciation Depletion And Amortization | $76.0K | $76.0K | $72.0K | $13.0K | $15.0K | $16.0K | ||||||||||
| Share Based Compensation | $9.4M | $8.2M | $7.3M | $6.6M | $3.5M | |||||||||||
| Payments To Acquire Available For Sale Securities Debt | $125.8M | $131.4M | $89.1M | $57.0M | $149.8M | $31.1M | ||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $159.0K | $0.00 | $3.0K | ||||||||||||
| Proceeds From Issuance Of Common Stock | -$36.0K | $1.6M | $14.3M | |||||||||||||
| Proceeds From Net Issuance Of Common Stock Under Equity Based Compensation Plans | $0.00 | $1.1M | -$36.0K | |||||||||||||
| Payments To Minority Shareholders | $656.0K | $3.8M | ||||||||||||||
| Increase Decrease In Accrued Income Taxes Payable | $0.00 | -$75.0K | $0.00 | |||||||||||||
| Proceeds From Issuance Initial Public Offering | $0.00 | $267.3M | ||||||||||||||
| Proceeds From Issuance Of Convertible Preferred Stock | $0.00 | $1.8M | $800.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.69 | $2.38 | -$1.52 | -$2.60 | ||
| Common Stock Shares Outstanding | 60.2M | 58.5M | 42.9M | 45.8M | 44.3M | 29.8M |
| Common Stock Shares Issued | 60.2M | 58.5M | 42.9M | 45.8M | 44.3M | 29.8M |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 34.9M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 41.6M | 45.2M | 43.1M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 41.6M | 46.6M | 43.1M | |||
| Earnings Per Share Basic | $-3.69 | $2.46 | $-1.52 | |||
| Preferred Stock Shares Outstanding | 555.9K | 647.5K | 647.5K | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 555.9K | 647.5K | 647.5K | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.69 | -$0.75 | -$0.86 | -$0.91 | -$0.82 | -$1.42 | -$0.54 | $3.77 | -$0.27 | -$0.40 | -$0.36 | $0.00 | -$0.50 | -$0.44 | -$0.27 | |||
| Common Stock Shares Outstanding | 59.1M | 59.1M | 58.7M | 58.1M | 57.9M | 43.1M | 42.8M | 42.7M | 39.3M | 45.7M | 45.4M | 44.7M | 43.7M | 43.5M | 43.5M | |||
| Common Stock Shares Issued | 59.1M | 59.1M | 58.7M | 58.1M | 57.9M | 43.1M | 42.8M | 42.7M | 39.3M | 45.7M | 45.4M | 44.7M | 43.7M | 43.5M | 43.5M | |||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 58.3M | 55.1M | 43.0M | 42.7M | 40.0M | 40.7M | 45.6M | 44.9M | 44.4M | 43.4M | 43.3M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 58.3M | 55.1M | 43.0M | 42.7M | 40.0M | 40.7M | 45.6M | 46.4M | 44.4M | 43.4M | 43.3M | |||||||
| Earnings Per Share Basic | $-0.69 | $-0.75 | $-0.86 | $-0.91 | $-0.82 | $-1.42 | $-0.54 | $3.90 | $-0.27 | $-0.40 | $-0.36 | |||||||
| Preferred Stock Shares Outstanding | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 0.00 | |||||||||
| Preferred Stock Shares Issued | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | 647.5K | |||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $22.2M | $29.7M | $21.6M | $6.6M | $477.0K | $888.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $8.0M | $538.0K | $6.0M | $3.3M | ||
| Prepaid Expense Current | $8.9M | $15.7M | $13.1M | $7.2M | $6.1M | $2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $5.1M | $5.9M | $6.6M | $8.4M | $8.1M | $5.7M | $5.9M | $5.3M | $4.5M | $2.4M | $697.0K | $197.0K | $118.0K | $173.0K | $49.0K | $185.0K | $246.0K | $378.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $373.0K | $2.0M | $3.3M | $1.1M | $112.0K | $214.0K | $36.0K | $1.4M | $2.8M | $1.6M | $579.0K | $180.0K | ||||||
| Prepaid Expense Current | $9.6M | $10.4M | $13.9M | $14.0M | $15.3M | $12.7M | $10.3M | $6.4M | $8.3M | $6.1M | $11.8M | $7.5M | $7.8M | $7.8M | $6.4M |
Most recent annual filing with the SEC: March 10, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.